...read the wave
Nano Products - Nano-Produkte - Nano Producten



Raymor Industries Begins Commercial Production of
Nano-Sized and Micron-Sized Titanium Powder for the Biomedical and Aerospace Markets


MONTREAL--(BUSINESS WIRE)--March 10, 2005--Raymor Industries (TSX VENTURE:RAR - News) is proud to announce that its wholly-owned, industrial subsidiary, AP&C Advanced Powders and Coatings Inc. (AP&C) will begin commercial production of nano-sized and micron-sized titanium powders, in order to meet immediate demands for this high value-added product with specific companies in the biomedical and aerospace sectors. AP&C is currently negotiating with a major US enterprise involved in the production and commercialization of biomedical products. This company is considering the commercialization of a new generation of innovative orthopedic implants produced using AP&C titanium powders. This US company had received approval from the Food & Drug Administration (FDA) for these productS manufactured using AP&C powders, which are produced using a patented process. Commercial applications for these implants can include hip and knee replacements, as well as other orthopedic implants.

Engineering studies performed over the last two months with regards to optimizing the capacity of the reactor have determined that AP&C will attain an optimal production capacity after the first three months of operation. At full capacity, revenues generated from the sale of titanium powder over a 12 month timeframe will surpass $3.5 million per reactor. AP&C powder production capacity will double with the installation of a second reactor in the coming months. The infrastructure is in place to build up to 6 reactors.

AP&C metal powders are produced using a unique, patented process, developed over 14 years at a cost of over $10 million. This process, developed in partnership with Hydro-Quebec, has been licensed to AP&C on an exclusive, worldwide basis. The exceptional qualities of AP&C powders are the sphericity and the purity obtained using the Plasma Atomization Process. The flowability of AP&C powders, given its spherical nature, allows for an evenly distributed coating on hip, knee and other artificial joints. Also, the high purity and sphericity of the powder provides components with an optimal porosity for encouraging human tissue growth, thus offering enhanced biocompatibility properties.

With regards to the potential market for AP&C titanium powders, the world market for orthopedic implants was more than US$6.4 billion in 2002. Analysts from the renowned Freedonia Group predict markets of US$8.7 billion in 2007 and US$11.6 billion in 2012. The overall growth rate for this sector will be 6.2%. However, Freedonia Group and Frost & Sullivan both agree that this growth rate can increase significantly (up to 15% per year), given the removal of certain anti-inflammatory and pain medications from the market place by the FDA. As well, an aging population will likely have an impact on the orthopedic implant market growth rate.

"We believe that the unique properties of our nano-sized and micron-sized metallic powders will allow AP&C to claim a significant portion of the biomedical market," confirms Stephane Robert, President of Raymor Industries & AP&C. "We also foresee the rapid commercialization of our powders in other innovative sectors. Several business opportunities in this area will be finalized shortly," added Mr. Robert.

RAYMOR INDUSTRIES INC. (TSX-V:RAR - News) has for mission to be the largest Canadian developer of high technology and a producer/recycler of advanced materials and nanomaterials for high value-added applications. In November 2004, Raymor Industries created an industrial subsidiary, AP&C Advanced Powders and Coatings, specializing in nanotechnology and advanced materials, and comprising four operational divisions: (1) metal and ceramic coatings, which largely targets aerospace, military, and mining applications; (2) spherical metallic powders, primarily used for biomedical and aerospace applications; (3) nanotechnology products, including nano-powders, nano-coatings, and carbon nanotubes for "the applications of tomorrow"; and (4) net-shape forming, a component manufacturing technique used for ballistic protection and other aerospace and military applications. Raymor holds the exclusive rights to 20 patents throughout the world.


Stephane Robert, President.


The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.


Raymor Industries Inc.
Raymond Fournel
Investor Relations
(514) 932-3485
Fax: (514) 932-3644

This story has been adapted from a news release -
Diese Meldung basiert auf einer Pressemitteilung -
Deze tekst is gebaseerd op een nieuwsbericht -


who is reading
the wave ?

missed some news ?
click on archive photo


or how about joining us


or contacting us ?


about us


our mission